34O ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss: Results from the ENGOT/GYN1/NCRI ATARI trial

Autor:	S. Banerjee, A. Leary, J.R. Stewart, M. Dewan, S. Lheureux, A.R. Clamp, I.L. Ray-Coquard, F. Selle, C. Gourley, R.M. Glasspool, R. Bowen, A. Attygalle, K. Vroobel, N. Tunariu, K. Wilkinson, C. Toms, R. Natrajan, J. Bliss, C. Lord, N. Porta
Rok vydání:	2023
Předmět:	Cancer Research Oncology
Zdroj:	ESMO Open. 8:100814
ISSN:	2059-7029
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::331c5d944406bb3d4bdb0c0e53f4bd0f https://doi.org/10.1016/j.esmoop.2023.100814 Zobrazit plný text záznamu